Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

Objective To quantify the risk of future cardiovascular diseases, cancer, and mortality after pre-eclampsia.Design Systematic review and meta-analysis.Data sources Embase and Medline without language restrictions, including papers published between 1960 and December 2006, and hand searching of refer...

Full description

Saved in:
Bibliographic Details
Published inBMJ Vol. 335; no. 7627; pp. 974 - 977
Main Authors Bellamy, Leanne, Casas, Juan-Pablo, Hingorani, Aroon D, Williams, David J
Format Journal Article
LanguageEnglish
Published London British Medical Journal Publishing Group 10.11.2007
British Medical Association
BMJ Publishing Group LTD
BMJ Publishing Group
BMJ Publishing Group Ltd
EditionInternational edition
Subjects
Online AccessGet full text
ISSN0959-8138
0959-8146
1756-1833
1468-5833
1756-1833
DOI10.1136/bmj.39335.385301.BE

Cover

More Information
Summary:Objective To quantify the risk of future cardiovascular diseases, cancer, and mortality after pre-eclampsia.Design Systematic review and meta-analysis.Data sources Embase and Medline without language restrictions, including papers published between 1960 and December 2006, and hand searching of reference lists of relevant articles and reviews for additional reports.Review methods Prospective and retrospective cohort studies were included, providing a dataset of 3 488 160 women, with 198 252 affected by pre-eclampsia (exposure group) and 29 495 episodes of cardiovascular disease and cancer (study outcomes).Results After pre-eclampsia women have an increased risk of vascular disease. The relative risks (95% confidence intervals) for hypertension were 3.70 (2.70 to 5.05) after 14.1 years weighted mean follow-up, for ischaemic heart disease 2.16 (1.86 to 2.52) after 11.7 years, for stroke 1.81 (1.45 to 2.27) after 10.4 years, and for venous thromboembolism 1.79 (1.37 to 2.33) after 4.7 years. No increase in risk of any cancer was found (0.96, 0.73 to 1.27), including breast cancer (1.04, 0.78 to 1.39) 17 years after pre-eclampsia. Overall mortality after pre-eclampsia was increased: 1.49 (1.05 to 2.14) after 14.5 years.Conclusions A history of pre-eclampsia should be considered when evaluating risk of cardiovascular disease in women. This association might reflect a common cause for pre-eclampsia and cardiovascular disease, or an effect of pre-eclampsia on disease development, or both. No association was found between pre-eclampsia and future cancer.
Bibliography:PMID:17975258
istex:C42CCD53B6F9835097229F6F549CF34647D28832
href:bmj-335-974.pdf
ark:/67375/NVC-GLF9ZP1R-F
local:bmj;335/7627/974
ArticleID:bell456806
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Feature-1
content type line 23
ObjectType-Review-3
ObjectType-Undefined-4
ISSN:0959-8138
0959-8146
1756-1833
1468-5833
1756-1833
DOI:10.1136/bmj.39335.385301.BE